Ascletis receives IND approval for its NASH drug

Clinical Research |  News | 0 Comment | 28 Aug, 2019

Ascletis Pharma Inc., an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical need...Read more

Abstract on Ph2 study of Varlitinib gets acceptance for oral prentation at CSCP 2019

Clinical Research |  News | 0 Comment | 27 Aug, 2019

ASLAN Pharmaceuticals a clinical-stage oncology and immunology focused biopharma company, on 27 August 2019, announ...Read more

First patient dosed for Phase I/II trial of avapritinib in advanced GIST

Clinical Research |  News | 0 Comment | 26 Aug, 2019

CStone Pharmaceuticals, on 26 August 2019, announced that the first patient in China has been dosed in Phase I/II b...Read more

New trial to evaluate an investigational drug for Parkinson's disease

Clinical Research |  News | 0 Comment | 26 Aug, 2019

Suncoast Neuroscience Associates is recruiting for a clinical research study to evaluate an investigational medication i...Read more

CStone registers for Phase I trial of CDK4/6 inhibitor CS3002 in Australia

Clinical Research |  News | 0 Comment | 23 Aug, 2019

CStone Pharmaceuticals, on 23 August 2019, announced that the Company has recently received ethics approval from the Hum...Read more

Luye Pharma's anti-depression drug to start clinical trials in Japan

Clinical Research |  News | 0 Comment | 22 Aug, 2019

Luye Pharma Group has announced its submission of the clinical trials application for a new chemical drug, Ansofaxine Hy...Read more

Janssen reports positive Ph3 results of long-acting injectable HIV treatment regimen

Clinical Research |  News | 0 Comment | 22 Aug, 2019

The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) have announced positive top-line results fr...Read more

AstraZeneca announces positive results for heart drug candidate

Clinical Research |  News | 0 Comment | 20 Aug, 2019

AstraZeneca, on 20 August 2019, announced positive results from the landmark Phase III DAPA-HF trial which showed that&n...Read more

CStone announces first patient dosed in China with BLU-667

Clinical Research |  News | 0 Comment | 13 Aug, 2019

CStone Pharmaceuticals, on 13 August 2019, announced the dosing of the first patient in China for the Phase I ...Read more

Jazz Pharma advances recombinant crisantaspase development program

Clinical Research |  News | 0 Comment | 08 Aug, 2019

Ireland based Jazz Pharmaceuticals plc has announced that the Phase 1 study of its recombinant crisantaspase molecu...Read more

DiscGenics treates First Patients in Japanese Clinical Trial of Cell Therapy for DDD

Clinical Research |  News | 0 Comment | 08 Aug, 2019

DiscGenics, Inc., a US based clinical-stage biotechnology company focused on developing regenerative cell-based therapie...Read more

SillaJen to discontinue PHOCUS trial for advanced liver cancer

Clinical Research |  News | 0 Comment | 06 Aug, 2019

SillaJen, Inc., a South Korea based clinical-stage, biotherapeutics company focused on the development of oncolytic immu...Read more

"Improving trial efficiency and lowering trial costs is a big challenge"

Clinical Research |  Opinion | 3 Comment | 05 Aug, 2019

Historically, getting patients in clinical trials is the biggest challenge to healthcare breakthrough. But now data can ...Read more

Botanix receives commitments for A$40M in US-led institutional placement

Clinical Research |  News | 0 Comment | 05 Aug, 2019

Australia headquartered Clinical stage cannabinoid company Botanix Pharmaceuticals has announced the receipt of firm com...Read more

Veristat expands operations into Taiwan

Clinical Research |  News | 0 Comment | 01 Aug, 2019

US headquartered Veristat, a scientifically oriented clinical development, and regulatory submission partner, announces ...Read more

CStone to initiate ivosidenib Phase I study in China

Clinical Research |  News | 0 Comment | 22 Jul, 2019

CStone Pharmaceuticals has received approval from China National Medical Products Administration (NMPA) to initiate a Ph...Read more

Kazia to use drug with radiotherapy for brain cancer treatment

Clinical Research |  News | 0 Comment | 23 Jul, 2019

Kazia Therapeutics Limited, an Australian oncology-focused biotechnology company, is pleased to announce that Memorial S...Read more

SOTIO initiates first-in-human clinical trial with IL-15 superagonist SO-C101

Clinical Research |  News | 0 Comment | 12 Jul, 2019

SOTIO and Cytune Pharma, members of the PPF Group have announced that the first dosing of cancer patients with ...Read more